ANIX
Anixa Biosciences, Inc. NASDAQ Listed Oct 7, 1983$2.67
-4.12%
vs $2.79
Mkt Cap $91.0M
52w Low $2.32
11.3% of range
52w High $5.46
50d MA $2.79
200d MA $3.30
P/E (TTM)
—
EV/EBITDA
—
P/B
6.2x
Debt/Equity
0.0x
ROE
-68.4%
P/FCF
-12.6x
RSI (14)
63.20
ATR (14)
$0.21
Beta
0.58
50d MA
$2.79
200d MA
$3.30
Avg Volume
185.0K
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
3150 Almaden Expressway · San Jose, CA 95118 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | AMC | -0.10 | -0.07 | +30.0% | 2.35 | +1.7% | +5.5% | -0.4% | +0.4% | +5.2% | +3.1% | — |
| Mar 9, 2026 | AMC | -0.09 | -0.08 | +11.1% | 2.98 | +1.0% | +0.0% | -1.3% | -2.7% | -1.0% | +0.4% | — |
| Jan 12, 2026 | AMC | -0.09 | -0.09 | -2.3% | 3.16 | +1.3% | +3.8% | +0.9% | -2.7% | -0.9% | -2.5% | — |
| Sep 10, 2025 | AMC | -0.10 | -0.07 | +30.0% | 3.02 | +0.7% | -2.3% | -0.3% | +19.7% | +2.3% | -6.9% | — |
| May 28, 2025 | AMC | -0.10 | -0.09 | +10.0% | 2.54 | +1.6% | +2.8% | -1.5% | +12.5% | -2.4% | -1.1% | — |
| Mar 11, 2025 | AMC | -0.10 | -0.10 | +0.0% | 2.66 | +0.4% | +0.8% | +4.9% | +5.3% | +2.4% | +0.7% | — |
| Jan 10, 2025 | AMC | -0.11 | -0.09 | +18.2% | 2.25 | -0.4% | -2.7% | -2.7% | +7.0% | +13.2% | -6.6% | — |
| Sep 6, 2024 | AMC | -0.11 | -0.10 | +9.1% | 3.21 | -1.6% | -1.2% | -1.9% | -0.6% | +7.4% | +0.9% | — |
| Jun 4, 2024 | AMC | -0.11 | -0.10 | +9.1% | 2.55 | +0.0% | -2.0% | -5.6% | +8.1% | +4.7% | -1.9% | — |
| Mar 12, 2024 | AMC | -0.09 | -0.10 | -11.1% | 3.08 | +2.6% | +3.2% | -3.1% | +19.8% | -4.9% | +2.6% | — |
| Jan 16, 2024 | AMC | -0.09 | -0.09 | +0.0% | 5.02 | -0.6% | -8.6% | +7.4% | +0.6% | -2.2% | +1.0% | — |
| Sep 6, 2023 | AMC | -0.09 | -0.08 | +11.1% | 3.53 | -0.8% | -5.7% | +1.8% | -0.6% | +2.7% | +3.2% | — |
| Jun 14, 2023 | AMC | -0.11 | -0.07 | +36.4% | 3.26 | +3.1% | +4.6% | -0.3% | +0.7% | -5.4% | +0.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8 | D. Boral Capital | Maintains | Buy → Buy | — | $2.69 | $2.79 | +3.7% | +1.5% | +0.4% | -1.8% | +5.9% | +1.1% |
| Mar 31 | D. Boral Capital | Maintains | Buy → Buy | — | $2.50 | $2.49 | -0.4% | +3.2% | +5.4% | -6.2% | +1.6% | +3.9% |
| Feb 4 | D. Boral Capital | Maintains | Buy → Buy | — | $3.04 | $3.06 | +0.7% | -3.9% | -5.8% | +7.6% | +0.7% | -0.3% |
| Dec 12 | D. Boral Capital | Maintains | Buy → Buy | — | $4.80 | $5.00 | +4.2% | -25.4% | -8.9% | +9.5% | -8.4% | -0.9% |
| Oct 7 | D. Boral Capital | Maintains | Buy → Buy | — | $3.25 | $3.40 | +4.6% | +26.5% | +8.0% | +10.8% | -12.0% | +4.4% |
| Sep 22 | D. Boral Capital | Maintains | Buy → Buy | — | $3.30 | $3.39 | +2.7% | +5.8% | -2.0% | +0.6% | -1.7% | +0.6% |
| Sep 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.02 | $3.04 | +0.7% | -2.3% | -0.3% | +19.7% | +2.3% | -6.9% |
| Sep 9 | D. Boral Capital | Maintains | Buy → Buy | — | $2.98 | $3.04 | +2.0% | +0.0% | +1.3% | -2.3% | -0.3% | +19.7% |
| Aug 19 | D. Boral Capital | Maintains | Buy → Buy | — | $2.98 | $3.00 | +0.7% | -0.3% | -1.7% | +1.0% | +3.7% | -2.0% |
| Aug 5 | D. Boral Capital | Maintains | Buy → Buy | — | $3.26 | $3.29 | +0.9% | -3.4% | -1.6% | -2.9% | -1.0% | -1.3% |
| Jun 10 | D. Boral Capital | Maintains | Buy → Buy | — | $3.40 | $3.50 | +2.9% | +2.6% | -2.0% | +5.3% | -7.2% | +12.3% |
| May 29 | D. Boral Capital | Maintains | Buy → Buy | — | $2.54 | $2.58 | +1.6% | +2.8% | -1.5% | +12.5% | -2.4% | -1.1% |
| Apr 10 | D. Boral Capital | Maintains | Buy → Buy | — | $2.69 | $2.69 | +0.0% | -1.1% | -3.0% | +2.7% | +7.5% | -3.5% |
| Mar 26 | D. Boral Capital | Maintains | Buy → Buy | — | $3.15 | $3.26 | +3.5% | +0.0% | -2.2% | -3.6% | -3.7% | -4.5% |
| Mar 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.20 | $3.21 | +0.3% | -1.6% | +0.0% | -2.2% | -3.6% | -3.7% |
| Feb 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.14 | $3.18 | +1.3% | -3.8% | -5.0% | +10.5% | -2.8% | -6.5% |
| Jan 22 | D. Boral Capital | Maintains | Buy → Buy | — | $2.81 | $3.15 | +12.1% | +6.0% | -2.0% | -3.4% | -1.4% | +0.7% |
| Jan 14 | D. Boral Capital | Maintains | Buy → Buy | — | $2.19 | $2.16 | -1.4% | -2.7% | +7.0% | +13.2% | -6.6% | +16.6% |
| Nov 19 | D. Boral Capital | Maintains | Buy → Buy | — | $3.05 | $3.05 | +0.0% | +2.3% | -2.2% | +0.3% | +4.6% | +0.6% |
| Nov 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.05 | $3.05 | +0.0% | +2.3% | -2.2% | +0.3% | +4.6% | +0.6% |
| Nov 11 | D. Boral Capital | Maintains | Buy → Buy | — | $3.44 | $3.43 | -0.3% | -3.2% | -2.4% | -4.6% | +1.0% | -1.6% |
| Sep 30 | EF Hutton | Maintains | Buy → Buy | — | $3.19 | $3.19 | +0.0% | -1.3% | +0.0% | +0.3% | -0.3% | +0.0% |
| Sep 24 | EF Hutton | Maintains | Buy → Buy | — | $3.23 | $3.40 | +5.3% | +4.6% | -6.8% | +1.0% | +0.3% | -1.3% |
| Sep 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.30 | $3.32 | +0.6% | +4.2% | +0.3% | -0.9% | +1.8% | -7.2% |
| Sep 9 | EF Hutton | Maintains | Buy → Buy | — | $3.21 | $3.16 | -1.6% | -1.2% | -1.9% | -0.6% | +7.4% | +0.9% |
| Jul 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.89 | $2.88 | -0.3% | -4.2% | +4.3% | +5.5% | +0.0% | +1.3% |
| Jun 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.55 | $2.60 | +2.0% | +4.7% | -1.9% | +0.8% | +3.0% | -4.0% |
| Mar 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.73 | $3.78 | +1.3% | -1.1% | -6.2% | -6.6% | -3.1% | +3.2% |
| Feb 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.46 | $4.48 | +0.4% | -3.6% | -0.5% | -4.7% | -0.7% | -4.7% |
| Dec 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.93 | $4.02 | +2.3% | -8.4% | +13.3% | +2.7% | -2.1% | -4.6% |
| Sep 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.28 | $3.28 | +0.0% | +3.0% | +5.6% | -5.9% | +1.2% | -1.5% |
| Aug 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.63 | $3.69 | +1.7% | +0.3% | +0.3% | +0.5% | -0.8% | -2.7% |
| Jul 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.55 | $3.55 | +0.0% | +2.3% | -1.1% | +1.1% | -0.6% | +4.7% |
| Jul 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.20 | $3.27 | +2.2% | -2.5% | +1.9% | +14.5% | +6.3% | -1.6% |
| Jun 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| May 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.45 | $3.45 | +0.0% | -0.3% | -2.6% | -2.1% | -1.8% | -1.9% |
| Mar 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.95 | $4.07 | +3.0% | +9.1% | +1.2% | +6.2% | -1.9% | +2.4% |
| Mar 22 | Chardan Capital | Maintains | Buy → Buy | — | $4.05 | $4.12 | +1.7% | -2.5% | +9.1% | +1.2% | +6.2% | -1.9% |
| Dec 30 | B. Riley | Maintains | Buy → Buy | — | $2.89 | $2.90 | +0.3% | +11.8% | +1.5% | -8.5% | +5.3% | +0.0% |
| Dec 30 | B. Riley Securities | Maintains | Buy → Buy | — | $2.89 | $2.90 | +0.3% | +11.8% | +1.5% | -8.5% | +5.3% | +0.0% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Titterton Lewis H jrDir | — | Buy | 2,836 | $2.64 | $7K | 972,170 | +8.18% | -4.38% |
| Jun 12, 2026 | KUMAR AMITDir/Off | Chief Executive Officer | Buy | 21,000 | $2.50 | $52K | 630,812 | +3.07% | -2.39% |
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
ANIX disclosed its annual meeting presentation materials for potential future investor use, suggesting the company is preparing standardized messaging for upcoming capital markets communications and analyst engagement.
Mar 11
8-K · 7.01
! Medium
Anixa Biosciences, Inc. -- 8-K 7.01: Regulation FD Disclosure
Anixa Biosciences announced positive survival data from its ovarian cancer CAR-T therapy Phase 1 trial and obtained regulatory clearance for dose escalation, potentially advancing the program toward later development stages.
Feb 9
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 1,314,982 | $3M | New | Mar 2026 |
| 2 | D.a. Davidson & Co. | 539,272 | $2M | Reduced | Dec 2025 |
| 3 | Ubs Group Ag | 551,637 | $1M | Added | Mar 2026 |
| 4 | Marshall Wace, Llp | 173,179 | $447K | Added | Mar 2026 |
| 5 | Morgan Stanley | 93,720 | $292K | Added | Dec 2025 |
| 6 | Susquehanna International Group, Llp | 99,468 | $257K | Reduced | Mar 2026 |
| 7 | Northern Trust Corp | 66,825 | $172K | Added | Mar 2026 |
| 8 | Renaissance Technologies Llc | 61,173 | $158K | Added | Mar 2026 |
| 9 | Corecap Advisors, Llc | 52,020 | $134K | Added | Mar 2026 |
| 10 | Hightower Advisors, Llc | 41,150 | $128K | — | Dec 2025 |
| 11 | Bank Of New York Mellon Corp | 47,442 | $122K | Reduced | Mar 2026 |
| 12 | Westside Investment Management, Inc. | 47,000 | $121K | Added | Mar 2026 |
| 13 | Gemmer Asset Management Llc | 35,000 | $90K | — | Mar 2026 |
| 14 | Cibc Bancorp Usa Inc. | 26,600 | $69K | New | Mar 2026 |
| 15 | Robertson Stephens Wealth Management, Llc | 15,649 | $49K | — | Dec 2025 |
| 16 | Dakota Wealth Management | 15,000 | $47K | — | Dec 2025 |
| 17 | Point72 Asset Management | 17,276 | $45K | Reduced | Mar 2026 |
| 18 | Keybank National Association/oh | 15,810 | $41K | — | Mar 2026 |
| 19 | Two Sigma Investments, Lp | 14,492 | $37K | New | Mar 2026 |
| 20 | Benjamin Edwards Inc | 11,200 | $35K | — | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 7
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund | 164,637 | $491K | Feb 2026 |
| 2 | iShares Micro-Cap ETF | 79,844 | $206K | Mar 2026 |
| 3 | Fidelity Total Market Index Fund | 52,694 | $157K | Feb 2026 |
| 4 | Fidelity Series Total Market Index Fund | 43,330 | $129K | Feb 2026 |
| 5 | Fidelity Nasdaq Composite Index Fund | 24,102 | $72K | Feb 2026 |
| 6 | Schwab Total Stock Market Index Fund | 12,785 | $39K | Jan 2026 |
| 7 | Victory Extended Market Index Fund | 3,136 | $10K | Jan 2026 |
Valuation
Market Cap
$91.0M
Enterprise Value
$75.4M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.96x
P/B
6.22x
P/S
—
P/FCF
-12.62x
EV/EBITDA
—
Shares Out
32.5M
Financials (TTM)
Revenue
$0
Net Income
-$10.1M
EBITDA
-$10.1M
Free Cash Flow
-$7.2M
Op Cash Flow
-$7.2M
EPS Basic
$-0.34
EPS Diluted
$-0.30
EPS Forward
$-0.33
Gross Margin
—
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$16.1M
Total Liab.
$2.1M
Total Equity
$13.9M
Cash
$15.2M
LT Debt
$0
Book Value/Sh
$0.43
Debt/Equity
0.01x
Current Ratio
8.08
Quick Ratio
8.08
Returns & Growth
ROE
-68.4%
ROA
-67.7%
ROIC
-82.7%
Rev Growth YoY
+0.0%
EPS Growth YoY
+12.8%
Price Returns
2W
+12.5%
1M
-10.0%
3M
-9.4%
6M
-41.2%
12M
+5.1%
Technicals
52W High
$5.46
52W Low
$2.32
50d MA
$2.79
200d MA
$3.30
RSI (14)
63.20
ATR (14)
$0.21
Beta
0.58
Avg Volume
185K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$5.83
High
$10.00
Low
$3.50
Median
$4.00
Data updated apr 24, 2026 6:11pm
· Source: financialmodelingprep.com